nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antiviral activity of selected antimicrobial peptides against vaccinia virus
|
Mohan, Ketha V.K. |
|
2010 |
86 |
3 |
p. 306-311 6 p. |
artikel |
2 |
Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice
|
Rowe, Jenny |
|
2010 |
86 |
3 |
p. 276-285 10 p. |
artikel |
3 |
Conservation of HHV-6 DNA polymerase processivity factor sequence and predicted structure suggests it as a target for antiviral development
|
Bonnafous, Pascale |
|
2010 |
86 |
3 |
p. 316-319 4 p. |
artikel |
4 |
Dengue virus replicons: Production of an interserotypic chimera and cell lines from different species, and establishment of a cell-based fluorescent assay to screen inhibitors, validated by the evaluation of ribavirin's activity
|
Massé, Nicolas |
|
2010 |
86 |
3 |
p. 296-305 10 p. |
artikel |
5 |
Editorial Board
|
|
|
2010 |
86 |
3 |
p. ii- 1 p. |
artikel |
6 |
Efficacy of 2′-C-methylcytidine against yellow fever virus in cell culture and in a hamster model
|
Julander, Justin G. |
|
2010 |
86 |
3 |
p. 261-267 7 p. |
artikel |
7 |
Lipophile-conjugated sulfated oligosaccharides as novel microbicides against HIV-1
|
Said, Joanna |
|
2010 |
86 |
3 |
p. 286-295 10 p. |
artikel |
8 |
Marine compounds and their antiviral activities
|
Yasuhara-Bell, Jarred |
|
2010 |
86 |
3 |
p. 231-240 10 p. |
artikel |
9 |
Notes to Authors
|
|
|
2010 |
86 |
3 |
p. CO3- 1 p. |
artikel |
10 |
Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus
|
Sauerbrei, A. |
|
2010 |
86 |
3 |
p. 246-252 7 p. |
artikel |
11 |
Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors in vitro
|
Bader, Ted |
|
2010 |
86 |
3 |
p. 241-245 5 p. |
artikel |
12 |
Slow binding–tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation
|
Samuele, Alberta |
|
2010 |
86 |
3 |
p. 268-275 8 p. |
artikel |
13 |
The antiretroviral potency of emtricitabine is approximately 3-fold higher compared to lamivudine in dual human immunodeficiency virus type 1 infection/competition experiments in vitro
|
Drogan, Daniel |
|
2010 |
86 |
3 |
p. 312-315 4 p. |
artikel |
14 |
The rare HIV-1 gp41 mutations 43T and 50V elevate enfuvirtide resistance levels of common enfuvirtide resistance mutations that did not impact susceptibility to sifuvirtide
|
Covens, Kris |
|
2010 |
86 |
3 |
p. 253-260 8 p. |
artikel |